Trademark: 97023072
Word
PHENOMICS HEALTH
Status
Pending
Status Code
630
Status Date
Wednesday, September 15, 2021
Serial Number
97023072
Mark Type
4000
Filing Date
Sunday, September 12, 2021

Trademark Owner History

Classifications
42 Scientific and technological services featuring testing, analysis and evaluation of human blood and other biological samples for the purpose of drug development by others, namely, data-driven analytics and reporting to developers of drugs; scientific and technological services featuring testing, analysis and evaluation of blood samples for the purpose of improving quality in the field of healthcare services, specifically for improving the monitoring and diagnostics of quantitative patient drug exposure, monitoring and diagnostics of patient drug compliance, data-driven analytics and reporting to providers of healthcare services in the field of pharmacovigilance activities, drug dosage recommendations, initial drug prescribing, and drug switching, all for research purposes and not for medical purposes; Software as a service (SaaS) services featuring software for use in medical research data collection and management, database management, allowing physicians to share and receive clinical data, monitoring patient data, monitoring patient clinical data, monitoring medications in a patient's circulation to support treatment decisions, analyzing and recording testing, analysis and evaluation of human blood and other biological samples for the purpose of improving the identification and quantitative measurement of patient drug exposure, improving the monitoring and diagnosis of patient drug compliance, improving drug selection and dosage recommendations, initial drug prescribing practices, and identifying drug-drug interactions, and developing clinical treatment decision support, other medical diagnostic products and prescription drugs for the purpose of improving patient outcomes in the field of healthcare; Platform as a Service (PaaS) featuring computer software that allows users to monitor patient data, patient clinical data, and medications in a patient's circulation to support treatment decisions; Providing an interactive website featuring technology that allows users to monitor patient data, patient clinical data, and medications in a patient's circulation to support treatment decisions; scientific and technological services, namely, providing medical and scientific research featuring testing, analysis and evaluation of blood samples for the purpose of improving the identification and quantitative measurement of patient drug exposure, improving the monitoring and diagnosis of patient drug compliance, improving drug selection and dosage recommendations, initial drug prescribing practices, and identifying drug-drug interactions, and developing clinical treatment decision support, other medical diagnostic products and prescription drugs; scientific and technological services in the nature of testing, analysis and evaluation of blood and other biological samples for research purposes and for research in the field of clinical trials; scientific and technological services for the purpose of combining pharmacogenomic drug treatment recommendations, identification and quantitative measurement of patient drug exposure with digital patient monitoring and digital therapy
44 Medical testing, namely, testing, analysis and evaluation of blood and other biological samples for clinical treatment decision support purposes; Medical testing services in the nature of testing, analysis and evaluation of blood samples for diagnostic and treatment purposes; Medical testing services in the nature of testing, analysis and evaluation of blood samples to combine increased predictability of patient-specific drug efficacy, appropriate dose, drug-drug interactions, and likely adverse drug reactions with precise measurement of patient response to improve patient treatment outcomes, avoid adverse drug reactions, and reduce patient treatment costs

Trademark Events
Sep 15, 2021
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24